AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Cushman & Wakefield plc

$12.7 -$3.14 (-19.82%)
NYSE · 14 Sep 2026 20:00 UTC
Previous Close
$12.9
Day Range
$12.65$13.12
Year Range
$11.57$17.4
Market Cap
2.98B
AVG Volume
1.99M
Trailing/Forward PE
43.52/7.37
PEG ratio
2.5
Dividend Yield
-
Next Earnings Date
2026-10-29
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
01B2B3B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CWK Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q22.76B
26 Q12.54B
25 Q42.91B
25 Q32.61B
25 Q22.48B
25 Q12.28B
24 Q42.63B
24 Q32.34B
24 Q22.29B
24 Q12.18B
Net Income (USD)
-50M050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CWK Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q252.7M
26 Q1-12.6M
25 Q4-22.4M
25 Q351.4M
25 Q257.3M
25 Q11.9M
24 Q4112.9M
24 Q333.7M
24 Q213.5M
24 Q1-28.8M
Operating Income (USD)
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CWK Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2134.2M
26 Q158.7M
25 Q4176.9M
25 Q3107.5M
25 Q2122.1M
25 Q145.3M
24 Q4174.5M
24 Q375.2M
24 Q270.4M
24 Q118.8M
EBITDA (USD)
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CWK EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2165.4M
26 Q164.9M
25 Q468.1M
25 Q3126.9M
25 Q2155.6M
25 Q178.5M
24 Q4215.5M
24 Q3118.2M
24 Q2119M
24 Q186.7M
Cash Flows (USD)
-400M-200M0200M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CWK Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q298.5M
26 Q1-255.7M
25 Q4234.3M
25 Q3225M
25 Q2300K
25 Q1-166.6M
24 Q4105.9M
24 Q3186.7M
24 Q210M
24 Q1-135.6M
EPS (USD)
-0.200.20.40.624 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CWK EPS (USD) by quarter
PeriodEPS (USD)
26 Q20.22
26 Q1-0.05
25 Q4-0.1
25 Q30.22
25 Q20.25
25 Q10.01
24 Q40.48
24 Q30.14
24 Q20.06
24 Q1-0.13
Expenses (USD)
-200M0200M400MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CWK Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q2337.1M
26 Q112.2M
25 Q4395.1M
25 Q3331.1M
25 Q2327.6M
25 Q1310.4M
24 Q4322.2M
24 Q3323.6M
24 Q2306M
24 Q1306.5M
Cash & Debt (USD)
01B2B3B4BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CWK Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q2500.5M
26 Q1600.6M
25 Q4784.2M
25 Q3634.4M
25 Q2618.2M
25 Q1623.2M
24 Q4793.3M
24 Q3775.4M
24 Q2567.3M
24 Q1553.5M
Debt ratios
0246824 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CWK Debt ratios by quarter
PeriodDebt ratios
26 Q25.95
26 Q16.06
25 Q45.73
25 Q34.29
25 Q24.62
25 Q14.99
24 Q44.67
24 Q35.26
24 Q25.7
24 Q15.8
Margins
0%10%20%30%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CWK Margins by quarter
PeriodMargins
26 Q216.47%
26 Q114.59%
25 Q417.97%
25 Q316.43%
25 Q217.76%
25 Q116.82%
24 Q420.1%
24 Q318.45%
24 Q218.06%
24 Q116.13%
Return on Capital
-2.5%0%2.5%5%7.5%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CWK Return on Capital by quarter
PeriodReturn on Capital
26 Q22.61%
26 Q1-0.65%
25 Q4-1.15%
25 Q32.63%
25 Q23.01%
25 Q10.11%
24 Q46.43%
24 Q31.98%
24 Q20.82%
24 Q1-1.77%
Shares Outstanding
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CWK Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2234.4M
26 Q1232.8M
25 Q4231.6M
25 Q3231.5M
25 Q2231.4M
25 Q1230.4M
24 Q4229.5M
24 Q3229.3M
24 Q2229M
24 Q1227.9M
Book Value Per Share (USD)
02.557.51024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CWK Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q28.63
26 Q18.39
25 Q48.44
25 Q38.46
25 Q28.23
25 Q17.71
24 Q47.65
24 Q37.43
24 Q27.16
24 Q17.13
Total Assets (USD)
02B4B6B8B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CWK Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q27.55B
26 Q17.65B
25 Q47.68B
25 Q37.69B
25 Q27.56B
25 Q17.41B
24 Q47.55B
24 Q37.53B
24 Q27.34B
24 Q17.49B
Employee Count
020K40K60K20182019202020212022202320242025
CWK Employee Count by quarter
PeriodEmployee Count
202553K
202452K
202352K
202252K
202150K
202050K
201953K
201851K
PE Ratio
050100150med 19.96Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CWK PE Ratio by quarter
PeriodPE Ratio
Sep 2643.08
Sep 2643.76
Sep 2646.34
Aug 2647.9
Aug 2650.27
Aug 2648.85
Aug 2646.91
Jul 2642.39
Jul 2640.18
Jul 2643.15
Jul 2642.61
Jul 2644.19
Jun 2643.12
Jun 2640.75
Jun 2642.64
Jun 2642.23
May 2639.29
May 2640.72
May 2639.33
May 2644.82
May 2637.05
Apr 2637.68
Apr 2638.42
Apr 2634.71
Apr 2632.77
Mar 2630.99
Mar 2631.09
Mar 2631.88
Mar 2633.24
Feb 2635.21
Feb 2635
Feb 2613.35
Feb 2616.74
Jan 2617.03
Jan 2616.79
Jan 2617.82
Jan 2617.21
Jan 2616.41
Dec 2517.12
Dec 2516.76
Dec 2515.84
Dec 2516.33
Nov 2517.35
Nov 2516.58
Nov 2516.03
Nov 2516.29
Oct 2516.26
Oct 2519.2
Oct 2517.72
Oct 2516.43
Oct 2517.82
Sep 2517.84
Sep 2518.71
Sep 2518.71
Sep 2518.65
Aug 2517.73
Aug 2517.52
Aug 2516.62
Aug 2515.39
Aug 2516.97
Jul 2516.9
Jul 2515.9
Jul 2516.64
Jul 2516.85
Jun 2515.83
Jun 2514.9
Jun 2514.81
Jun 2514.58
May 2514.26
May 2513.7
May 2515
May 2514.59
May 2514.34
Apr 2515.38
Apr 2514.47
Apr 2514.09
Apr 2515.73
Mar 2517.81
Mar 2518.25
Mar 2518.69
Mar 2519.58
Feb 2520.78
Feb 2520.35
Feb 2534.42
Feb 2533.95
Jan 2535.85
Jan 2535.12
Jan 2534.63
Jan 2530.68
Jan 2533.33
Dec 2433.98
Dec 2434.03
Dec 2438.66
Dec 2439.23
Nov 2439.78
Nov 2437.54
Nov 2435.98
Nov 2438.79
Nov 24144.85
Oct 24148.96
Free Cash Flow Yield
2%4%6%8%10%12%med 6.49%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CWK Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2610.15%
Sep 269.99%
Sep 269.44%
Aug 269.13%
Aug 268.7%
Aug 268.95%
Aug 269.32%
Jul 266.53%
Jul 266.89%
Jul 266.41%
Jul 266.49%
Jul 266.26%
Jun 266.42%
Jun 266.79%
Jun 266.49%
Jun 266.55%
May 267.04%
May 266.79%
May 267.04%
May 266.17%
May 268.97%
Apr 268.82%
Apr 268.65%
Apr 269.57%
Apr 2610.14%
Mar 2610.72%
Mar 2610.69%
Mar 2610.42%
Mar 269.99%
Feb 269.43%
Feb 269.49%
Feb 265.52%
Feb 264.4%
Jan 264.32%
Jan 264.39%
Jan 264.13%
Jan 264.28%
Jan 264.49%
Dec 254.3%
Dec 254.39%
Dec 254.65%
Dec 254.51%
Nov 254.24%
Nov 254.44%
Nov 254.59%
Nov 254.52%
Oct 254.53%
Oct 253.2%
Oct 253.46%
Oct 253.74%
Oct 253.44%
Sep 253.44%
Sep 253.28%
Sep 253.28%
Sep 253.29%
Aug 253.46%
Aug 253.5%
Aug 253.69%
Aug 253.99%
Aug 254.95%
Jul 254.97%
Jul 255.28%
Jul 255.05%
Jul 254.98%
Jun 255.3%
Jun 255.63%
Jun 255.67%
Jun 255.76%
May 255.89%
May 256.13%
May 255.6%
May 255.75%
May 255.86%
Apr 258.27%
Apr 258.79%
Apr 259.03%
Apr 258.09%
Mar 257.14%
Mar 256.97%
Mar 256.81%
Mar 256.5%
Feb 256.12%
Feb 256.25%
Feb 258.15%
Feb 258.26%
Jan 257.82%
Jan 257.98%
Jan 258.1%
Jan 259.14%
Jan 258.41%
Dec 248.25%
Dec 248.24%
Dec 247.25%
Dec 247.15%
Nov 247.05%
Nov 247.47%
Nov 247.79%
Nov 247.23%
Nov 247.86%
Oct 247.64%
Price to Sales
0.10.20.30.40.5med 0.31Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CWK Price to Sales by quarter
PeriodPrice to Sales
Sep 260.28
Sep 260.28
Sep 260.3
Aug 260.31
Aug 260.32
Aug 260.31
Aug 260.3
Jul 260.3
Jul 260.28
Jul 260.3
Jul 260.3
Jul 260.31
Jun 260.3
Jun 260.28
Jun 260.3
Jun 260.3
May 260.27
May 260.28
May 260.28
May 260.31
May 260.32
Apr 260.32
Apr 260.33
Apr 260.3
Apr 260.28
Mar 260.27
Mar 260.27
Mar 260.27
Mar 260.28
Feb 260.3
Feb 260.3
Feb 260.3
Feb 260.37
Jan 260.38
Jan 260.38
Jan 260.4
Jan 260.38
Jan 260.37
Dec 250.38
Dec 250.37
Dec 250.35
Dec 250.36
Nov 250.39
Nov 250.37
Nov 250.36
Nov 250.36
Oct 250.36
Oct 250.41
Oct 250.37
Oct 250.35
Oct 250.38
Sep 250.38
Sep 250.4
Sep 250.4
Sep 250.39
Aug 250.37
Aug 250.37
Aug 250.35
Aug 250.33
Aug 250.29
Jul 250.29
Jul 250.27
Jul 250.28
Jul 250.29
Jun 250.27
Jun 250.25
Jun 250.25
Jun 250.25
May 250.24
May 250.23
May 250.25
May 250.25
May 250.24
Apr 250.21
Apr 250.2
Apr 250.2
Apr 250.22
Mar 250.25
Mar 250.25
Mar 250.26
Mar 250.27
Feb 250.29
Feb 250.28
Feb 250.32
Feb 250.32
Jan 250.34
Jan 250.33
Jan 250.33
Jan 250.29
Jan 250.31
Dec 240.32
Dec 240.32
Dec 240.36
Dec 240.37
Nov 240.37
Nov 240.35
Nov 240.34
Nov 240.37
Nov 240.32
Oct 240.33
EV/EBITDA
810121416med 11.26Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CWK EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2612.95
Sep 2613.06
Sep 2613.48
Aug 2613.73
Aug 2614.11
Aug 2613.88
Aug 2613.57
Jul 2613.58
Jul 2613.19
Jul 2613.72
Jul 2613.62
Jul 2613.9
Jun 2613.71
Jun 2613.29
Jun 2613.63
Jun 2613.55
May 2613.03
May 2613.29
May 2613.04
May 2614.01
May 2613.35
Apr 2613.48
Apr 2613.63
Apr 2612.87
Apr 2612.47
Mar 2612.1
Mar 2612.12
Mar 2612.28
Mar 2612.56
Feb 2612.97
Feb 2612.92
Feb 269.47
Feb 2610.78
Jan 2610.9
Jan 2610.8
Jan 2611.2
Jan 2610.97
Jan 2610.65
Dec 2510.93
Dec 2510.79
Dec 2510.43
Dec 2510.63
Nov 2511.02
Nov 2510.72
Nov 2510.51
Nov 2510.61
Oct 2510.6
Oct 2511.58
Oct 2511.04
Oct 2510.57
Oct 2511.08
Sep 2511.09
Sep 2511.4
Sep 2511.4
Sep 2511.38
Aug 2511.05
Aug 2510.97
Aug 2510.64
Aug 2510.2
Aug 2510.16
Jul 2510.14
Jul 259.84
Jul 2510.06
Jul 2510.13
Jun 259.82
Jun 259.54
Jun 259.51
Jun 259.44
May 259.34
May 259.17
May 259.57
May 259.44
May 259.36
Apr 258.42
Apr 258.19
Apr 258.1
Apr 258.5
Mar 259.01
Mar 259.11
Mar 259.22
Mar 259.44
Feb 259.73
Feb 259.62
Feb 2511.4
Feb 2511.32
Jan 2511.66
Jan 2511.53
Jan 2511.44
Jan 2510.73
Jan 2511.21
Dec 2411.32
Dec 2411.33
Dec 2412.16
Dec 2412.26
Nov 2412.36
Nov 2411.96
Nov 2411.68
Nov 2412.18
Nov 2411.64
Oct 2411.81
Price/Operating Cashflow
510152025med 12.13Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CWK Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 268.87
Sep 269.01
Sep 269.54
Aug 269.86
Aug 2610.35
Aug 2610.06
Aug 269.66
Jul 2612.07
Jul 2611.44
Jul 2612.28
Jul 2612.13
Jul 2612.58
Jun 2612.27
Jun 2611.6
Jun 2612.14
Jun 2612.02
May 2611.19
May 2611.59
May 2611.19
May 2612.76
May 269.6
Apr 269.76
Apr 269.95
Apr 268.99
Apr 268.49
Mar 268.03
Mar 268.06
Mar 268.26
Mar 268.61
Feb 269.12
Feb 269.07
Feb 2615.05
Feb 2618.87
Jan 2619.19
Jan 2618.92
Jan 2620.08
Jan 2619.4
Jan 2618.49
Dec 2519.3
Dec 2518.89
Dec 2517.85
Dec 2518.41
Nov 2519.55
Nov 2518.69
Nov 2518.07
Nov 2518.36
Oct 2518.33
Oct 2524.87
Oct 2522.95
Oct 2521.28
Oct 2523.08
Sep 2523.11
Sep 2524.23
Sep 2524.23
Sep 2524.16
Aug 2522.97
Aug 2522.69
Aug 2521.52
Aug 2519.94
Aug 2516.06
Jul 2516
Jul 2515.05
Jul 2515.75
Jul 2515.96
Jun 2514.99
Jun 2514.11
Jun 2514.02
Jun 2513.8
May 2513.51
May 2512.97
May 2514.21
May 2513.82
May 2513.57
Apr 259.71
Apr 259.14
Apr 258.89
Apr 259.93
Mar 2511.24
Mar 2511.52
Mar 2511.79
Mar 2512.36
Feb 2513.12
Feb 2512.84
Feb 2510.28
Feb 2510.14
Jan 2510.71
Jan 2510.49
Jan 2510.35
Jan 259.17
Jan 259.96
Dec 2410.15
Dec 2410.17
Dec 2411.55
Dec 2411.72
Nov 2411.88
Nov 2411.22
Nov 2410.75
Nov 2411.59
Nov 2410.39
Oct 2410.68
Price to Book
11.522.5med 1.65Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CWK Price to Book by quarter
PeriodPrice to Book
Sep 261.47
Sep 261.5
Sep 261.58
Aug 261.64
Aug 261.72
Aug 261.67
Aug 261.6
Jul 261.6
Jul 261.52
Jul 261.63
Jul 261.61
Jul 261.67
Jun 261.63
Jun 261.54
Jun 261.61
Jun 261.59
May 261.48
May 261.54
May 261.48
May 261.69
May 261.67
Apr 261.7
Apr 261.73
Apr 261.57
Apr 261.48
Mar 261.4
Mar 261.4
Mar 261.44
Mar 261.5
Feb 261.59
Feb 261.58
Feb 261.52
Feb 261.91
Jan 261.94
Jan 261.92
Jan 262.03
Jan 261.97
Jan 261.87
Dec 251.95
Dec 251.91
Dec 251.81
Dec 251.86
Nov 251.98
Nov 251.89
Nov 251.83
Nov 251.86
Oct 251.86
Oct 252.08
Oct 251.92
Oct 251.78
Oct 251.93
Sep 251.93
Sep 252.02
Sep 252.02
Sep 252.02
Aug 251.92
Aug 251.89
Aug 251.8
Aug 251.66
Aug 251.55
Jul 251.54
Jul 251.45
Jul 251.52
Jul 251.54
Jun 251.44
Jun 251.36
Jun 251.35
Jun 251.33
May 251.3
May 251.25
May 251.37
May 251.33
May 251.31
Apr 251.15
Apr 251.08
Apr 251.05
Apr 251.18
Mar 251.33
Mar 251.36
Mar 251.4
Mar 251.46
Feb 251.55
Feb 251.52
Feb 251.78
Feb 251.76
Jan 251.86
Jan 251.82
Jan 251.79
Jan 251.59
Jan 251.73
Dec 241.76
Dec 241.76
Dec 242
Dec 242.03
Nov 242.06
Nov 241.94
Nov 241.86
Nov 242.01
Nov 241.82
Oct 241.87
Cushman & Wakefield plc
CWK
Stockpicker

Video analysis: CWK

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CWK

Cushman & Wakefield Insider Sells 12,500 Shares

fool.com · 12 Sep 2026

Cushman & Wakefield Insider Sells 12,500 Shares

The sale, conducted on Sept. 8, was valued at $167,375.

Cushman & Wakefield: U.S. Legal Sector Leasing Hits Record 7.3 Million Square Feet in Q2 2026 as Law Firms Expand Footprints

businesswire.com · 10 Sep 2026

Cushman & Wakefield: U.S. Legal Sector Leasing Hits Record 7.3 Million Square Feet in Q2 2026 as Law Firms Expand Footprints

NEW YORK--(BUSINESS WIRE)-- #cre--U.S. legal sector leasing reached a quarterly record of 7.3 million square feet (sf) in the second quarter of 2026, surpassing the previous quarterly high by 23%, according to a new report from Cushman & Wakefield. First-half legal leasing reached nearly 12.2 million sf, up 17% year over year, as law firm demand continued to contribute to the recovery in U.S. office leasing. “The legal sector is showing a clear preference for larger footprints, with expansion acti.

Cushman & Wakefield Ltd (CWK) Shares Surge 3.4% -- What GF Score of 76 Tells Investors

gurufocus.com · 3 Sep 2026

Cushman & Wakefield Ltd (CWK) Shares Surge 3.4% -- What GF Score of 76 Tells Investors

On September 03, 2026, Cushman and Wakefield Ltd (CWK) shares rose 3.4% to a current price of $13.48. This increase comes amidst a challenging year for the stock,

Cushman & Wakefield Releases 2026 Data Center Development Cost Guide, Citing 21% Rise in Per-MW Construction Costs

businesswire.com · 3 Sep 2026

Cushman & Wakefield Releases 2026 Data Center Development Cost Guide, Citing 21% Rise in Per-MW Construction Costs

NEW YORK--(BUSINESS WIRE)-- #cre--Cushman & Wakefield (NYSE: CWK), a leading global commercial real estate services firm, has published its 2026 Data Center Development Cost Guide, revealing that data center construction costs have risen an average of 21% per megawatt (MW) since the previous edition was published in the fourth quarter of 2024. Covering markets across the United States and Canada, the guide provides a comprehensive overview of data center development economics spanning land acquisi.

Cushman & Wakefield: U.S. Life Sciences Market Moves Toward Rebalancing as Capital Returns and New Development Slows

businesswire.com · 31 Aug 2026

Cushman & Wakefield: U.S. Life Sciences Market Moves Toward Rebalancing as Capital Returns and New Development Slows

NEW YORK--(BUSINESS WIRE)-- #cre--The U.S. life sciences real estate sector is moving toward a gradual rebalancing as development activity contracts, investment sales recover and funding conditions strengthen, according to the latest Life Sciences Update from Cushman & Wakefield. While elevated vacancy and softer rents continue to weigh on near-term fundamentals, a reduced construction pipeline and improving demand indicators are positioning the market for healthier long-term growth. U.S. life sci.

Cushman & Wakefield Strengthens Capital Markets Platform with Addition of Loan Restructuring Expert Steve Klein

businesswire.com · 24 Aug 2026

Cushman & Wakefield Strengthens Capital Markets Platform with Addition of Loan Restructuring Expert Steve Klein

NEW YORK--(BUSINESS WIRE)-- #cre--Cushman & Wakefield (NYSE: CWK) today announced the addition of Steve Klein to its Equity, Debt & Structured Finance team as Managing Director and Loan Restructuring Practice Lead. "Steve's expertise in loan restructuring is precisely the kind of sharp, specialized capability that strengthens our platform," said Miles Treaster, President, Americas Capital Markets at Cushman & Wakefield. "His ability to work across asset classes and capital structures will.

Are Investors Undervaluing Cushman & Wakefield (CWK) Right Now?

zacks.com · 18 Aug 2026

Are Investors Undervaluing Cushman & Wakefield (CWK) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Cushman & Wakefield to Lease 1.1 MSF Industrial Facility in Phoenix on behalf of GO Industrial

businesswire.com · 18 Aug 2026

Cushman & Wakefield to Lease 1.1 MSF Industrial Facility in Phoenix on behalf of GO Industrial

PHOENIX--(BUSINESS WIRE)-- #CRE--GO Industrial has broken ground on a 1,100,500-square-foot (sf) industrial building located at 9797 W. Buckeye Road in Phoenix, which is set to deliver in Q2 2027. The building represents the sole 1 million square foot opportunity currently available in the market. "GO 99 North answers a genuine shortage of million-square-foot-plus buildings in this market, and it strengthens a corridor we're deeply invested in,” said Robert Guerena, managing partner at GO Industrial.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.